SCHEMBL8006637

SCHEMBL8006637

C=CCCCCCCC(=O)N1CCC[C@H]1C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 2/20 0.47
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PKM P14618 1/20 0.46
POLB P06746 1/20 0.43
ACE P12821 1/20 0.42
FKBP1A P62942 1/20 0.41
SPHK1 Q9NYA1 1/20 0.41
DPP4 P27487 1/20 0.40
PEPD P12955 1/20 0.40
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5491755 0.88 LMNA (0.54) ALDH1A1LMNARAB9ASMN1; SMN2PKM
SCHEMBL5491765 0.88 LMNA (0.54) ALDH1A1LMNARAB9ASMN1; SMN2PKM
SCHEMBL6882664 0.88 LMNA (0.54) ALDH1A1LMNARAB9ASMN1; SMN2PKM
SCHEMBL16116975 0.86 SPHK1 (0.43) FKBP1ASPHK1
SCHEMBL15624148 0.86 SPHK1 (0.43) FKBP1ASPHK1
SCHEMBL15624129 0.86 SPHK1 (0.41) ALDH1A1LMNAACESPHK1HTR1A
SCHEMBL15624144 0.86 SPHK1 (0.41) ALDH1A1LMNAACESPHK1HTR1A
SCHEMBL10424382 0.85 LMNA (0.44) LMNARAB9ASMN1; SMN2PKMPOLB
SCHEMBL10424383 0.85 LMNA (0.44) LMNARAB9ASMN1; SMN2PKMPOLB
SCHEMBL10424384 0.85 LMNA (0.44) LMNARAB9ASMN1; SMN2PKMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009139792-A1 HCV PROTEASE INHIBITORS TAIGEN BIOTECHNOLOGY CO., LTD. (TW) 2009-11-19 WO disclosed
WO-2006043145-A1 INHIBITORS OF HEPATITIS C VIRUS PROTEASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME PFIZER INC. (US) 2006-04-27 WO disclosed